Literature DB >> 26401260

Pulmonary capillary hemangiomatosis: the role of invasive cardiopulmonary exercise testing.

Hilary M DuBrock1, Richard L Kradin1, Josanna M Rodriguez-Lopez1, Richard N Channick1.   

Abstract

Pulmonary capillary hemangiomatosis (PCH) is a rare form of pulmonary arterial hypertension (PAH) characterized by pulmonary capillary proliferation and pseudoinvasion of collagenous septal structures. PCH is often accompanied by veno-occlusive changes and pulmonary hypertensive arterial remodeling. The clinical and pathological diagnosis of PCH can be subtle and easily missed. Most reported cases of PCH have been associated with resting PAH. We report the cases of 3 patients who initially presented with exertional dyspnea with normal to mildly elevated resting pulmonary arterial pressures and marked intrapulmonary shunting. In all 3 patients, invasive cardiopulmonary exercise testing was suggestive of pulmonary vascular disease. Owing to abnormalities on invasive exercise testing, lung biopsies were performed; these were diagnostic of PCH, and the patients were referred for lung transplantation. We describe unique features of these 3 cases-including novel pathological findings and the presence of intrapulmonary shunting in all 3 patients-and we discuss the role of cardiopulmonary exercise testing in the evaluation of PCH.

Entities:  

Keywords:  cardiopulmonary exercise test; intrapulmonary shunt; pulmonary arterial hypertension; pulmonary arteriovenous malformation; pulmonary capillary hemangiomatosis

Year:  2015        PMID: 26401260      PMCID: PMC4556510          DOI: 10.1086/682227

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  26 in total

1.  Pulmonary capillary hemangiomatosis-like foci. An autopsy study of 8 cases.

Authors:  D M Havlik; L W Massie; W L Williams; L A Crooks
Journal:  Am J Clin Pathol       Date:  2000-05       Impact factor: 2.493

Review 2.  An autopsy case of pulmonary capillary hemangiomatosis without evidence of pulmonary hypertension.

Authors:  H Umezu; M Naito; K Yagisawa; A Hattori; Y Aizawa
Journal:  Virchows Arch       Date:  2001-10       Impact factor: 4.064

Review 3.  Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases.

Authors:  Gregory D Lewis; Eduardo Bossone; Robert Naeije; Ekkehard Grünig; Rajeev Saggar; Patrizio Lancellotti; Stefano Ghio; Janos Varga; Sanjay Rajagopalan; Ronald Oudiz; Melvyn Rubenfire
Journal:  Circulation       Date:  2013-09-24       Impact factor: 29.690

4.  Comparison of progressive exercise performance of normal subjects and patients with primary pulmonary hypertension.

Authors:  G E D'Alonzo; L A Gianotti; R L Pohil; R R Reagle; S L DuRee; F Fuentes; D R Dantzker
Journal:  Chest       Date:  1987-07       Impact factor: 9.410

5.  Imatinib is partially effective for the treatment of pulmonary capillary hemangiomatosis.

Authors:  Shiro Adachi; Akihiro Hirashiki; Takahisa Kondo; Masato Nakaguro; Aiko Ogawa; Katsumasa Miyaji; Hiromi Matsubara; Toyoharu Yokoi; Toyoaki Murohara
Journal:  Intern Med       Date:  2014       Impact factor: 1.271

6.  Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a.

Authors:  C W White; H M Sondheimer; E C Crouch; H Wilson; L L Fan
Journal:  N Engl J Med       Date:  1989-05-04       Impact factor: 91.245

Review 7.  From the Archives of the AFIP: pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.

Authors:  Aletta Ann Frazier; Teri J Franks; Tan-Lucien H Mohammed; Irem H Ozbudak; Jeffrey R Galvin
Journal:  Radiographics       Date:  2007 May-Jun       Impact factor: 5.333

8.  Pulmonary capillary hemangiomatosis arising in hereditary hemorrhagic telangiectasia.

Authors:  Heike Varnholt; Richard Kradin
Journal:  Hum Pathol       Date:  2004-02       Impact factor: 3.466

9.  Imatinib for the treatment of pulmonary arterial hypertension and pulmonary capillary hemangiomatosis.

Authors:  Dhruv Nayyar; Kavitha Muthiah; Gayathri Kumarasinghe; Ravin Hettiarachchi; David Celermajer; Eugene Kotlyar; Anne Keogh
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

Review 10.  Pulmonary capillary hemangiomatosis: a clinicopathologic review.

Authors:  M A Eltorky; A S Headley; H Winer-Muram; H E Garrett; J P Griffin
Journal:  Ann Thorac Surg       Date:  1994-03       Impact factor: 4.330

View more
  4 in total

1.  Mapping cardiopulmonary dynamics within the microvasculature of the lungs using dissolved 129Xe MRI.

Authors:  Peter J Niedbalski; Elianna A Bier; Ziyi Wang; Matthew M Willmering; Bastiaan Driehuys; Zackary I Cleveland
Journal:  J Appl Physiol (1985)       Date:  2020-06-18

2.  Capillary Proliferation in Systemic-Sclerosis-Related Pulmonary Fibrosis: Association with Pulmonary Hypertension.

Authors:  Atsuko Seki; Zafia Anklesaria; Rajeev Saggar; Mark W Dodson; Kristin Schwab; Ming-Chang Liu; Deepshikha Charan Ashana; William D Miller; Sitaram Vangala; Ariss DerHovanessian; Richard Channick; Faisal Shaikh; John A Belperio; Stephen S Weigt; Joseph P Lynch; David J Ross; Lauren Sullivan; Dinesh Khanna; Shelley S Shapiro; Jeffrey Sager; Luna Gargani; Anna Stanziola; Eduardo Bossone; Dean E Schraufnagel; Gregory Fishbein; Haodong Xu; Michael C Fishbein; William D Wallace; Rajan Saggar
Journal:  ACR Open Rheumatol       Date:  2019-03-15

3.  Pulmonary arterial hypertension associated with pulmonary arteriovenous malformations and pulmonary veno-occlusive disease: A devastating combination.

Authors:  Baukje M Zaaijer; Nienke Duppen; Brigitte W M Willemse; Martijn V Verhagen; Marcus T R Roofthooft; Wim Timens; Rolf M F Berger; Johannes M Douwes
Journal:  Respir Med Case Rep       Date:  2021-12-01

4.  Progression of pulmonary veno-occlusive disease without pulmonary hypertension.

Authors:  Sarah Beshay; Marc Humbert; Roberto Barrios; Sandeep Sahay
Journal:  Pulm Circ       Date:  2022-02-21       Impact factor: 2.886

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.